Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction - Wikidata - awgldk - TriplyDB

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

http://www.wikidata.org/entity/Q28078254

about

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

http://www.wikidata.org/entity/Q28078254

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@ast

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@en

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@nl

type

label

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@ast

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@en

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@nl

prefLabel

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@ast

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@en

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@nl

P1433

Q28078254-F9B18397-B399-40E3-A307-89510DCB6BAF

P1476

Q28078254-1CB8973D-0AC4-4ABA-9A1B-C271B3C912FD

P2093

Q28078254-1312BA9A-0731-4F99-856B-C7652EFF6B1C

Q28078254-27E39381-E9FD-4A0C-A17C-134C36197967

Q28078254-5D42ED15-F9C9-4E5E-A473-6DB8A68A8622

Q28078254-9DB502D2-872E-4E9A-9C53-D987ADE88C21

Q28078254-E91B1944-2834-4CA5-B66D-6AF6A9437558

P2860

Q28078254-2C925EAB-DB9A-49E4-9583-E22BD0713380

Q28078254-3C004729-2A00-450A-8740-09C58ED320AD

Q28078254-418F08C8-5BEA-480E-8753-E75FB0C6F5D3

Q28078254-5ED27D5A-8F9C-42AD-AB5D-DA9A8F1D2C39

Q28078254-6F587D23-6BF4-4D63-B363-5F2139141BDE

Q28078254-98866FB3-2F2E-44F2-999B-FB3530B75832

Q28078254-AFF4534A-DC02-4B84-AB30-38239F375325

Q28078254-B975B739-4872-4F56-8F65-38BFAE4C28D2

Q28078254-C66DBEF4-F57C-45D2-AB6D-E63264CDC83B

Q28078254-CD34B34D-E16E-4D32-9237-A72C53DDDCDC

P2888

Q28078254-DF199D0B-6C5B-46FA-A0AC-A5D56BB5DF4A

P304

Q28078254-215B96D0-D3FC-4018-8D08-A927B1DFA702

P31

Q28078254-6C9E0D0A-2E23-4E86-9B98-E13F82FD27BA

P356

Q28078254-C1B6FD15-F131-46AD-BBF8-B777277D02B8

P407

Q28078254-3F7E5EEE-B777-4F36-852D-764921CA55A2

P433

Q28078254-DA540EED-E62F-45B2-AEBC-F576C7E68C67

P478

Q28078254-BDFAFDE3-2998-4C84-97AB-0AED3D05450D

P577

Q28078254-3A04FDD8-73AF-4D88-A587-237B95846F26

P5875

Q28078254-0A1A27C0-C216-47BA-A683-7401590DEBC3

P6179

Q28078254-01E1DF99-DBE6-41DC-A31C-6CB80374E47A

P698

Q28078254-4F4196C6-46B9-4881-A714-CBEF493B7AF9

P921

Q28078254-9AE4FAFE-8CED-4B9C-8497-81284D0C0DC8

P932

Q28078254-FD216BFF-BF4F-4BA0-B772-8928EDCA180B

P356

S40800-015-0012-6

P1433

Drug safety - case reports

P1476

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction

@en

P2093

Ayşegül Uludağ

http://www.w3.org/2001/XMLSchema#string

Burkay Yakar

http://www.w3.org/2001/XMLSchema#string

Hülya Ertekin

http://www.w3.org/2001/XMLSchema#string

Murat Tekin

http://www.w3.org/2001/XMLSchema#string

Yusuf Haydar Ertekin

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.

Cytochromes P450 and metabolism of xenobiotics.

Pathophysiology and clinical presentations of rhabdomyolysis.

Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

Rhabdomyolysis: a review of the literature.

Does inhibition of P-glycoprotein lead to drug-drug interactions?

Predicting drug-drug interactions: an FDA perspective

Case report: diclofenac-induced rhabdomyolysis.

Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration.

P2888

s40800-015-0012-6

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40800-015-0012-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282544764

http://www.w3.org/2001/XMLSchema#string

P6179

1041508302

http://www.w3.org/2001/XMLSchema#string

P698

27747722

http://www.w3.org/2001/XMLSchema#string

P921

P932

5005763

http://www.w3.org/2001/XMLSchema#string